天山股份(000877.SZ):3.35億元成功摘牌屯河水泥49%股權
格隆匯12月17日丨天山股份(000877.SZ)公佈,中糧屯河糖業股份有限公司(“中糧糖業”)將其持有的新疆屯河水泥有限責任公司(“屯河水泥”)49%股權在北京產權交易所公開掛牌轉讓。
2019年12月16日,公司成功摘牌屯河水泥49%股權,成交價格為人民幣3.35億元。同日,公司與中糧糖業簽署了《產權交易合同》並收到北京產權交易所出具的《企業國有資產交易憑證》。
此次交易正在辦理股權變更相關手續。上述股權交易完成後,公司將持有新疆屯河水泥有限責任公司100%股權,具體會計處理以會計師年度審計確認的結果為準,敬請投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.